Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines

被引:42
|
作者
Amarillo, Maria Lourdes E. [1 ]
Belizario, Vicente Y., Jr. [2 ]
Sadiang-abay, Jewel T. [3 ]
Sison, Stephanie Anne M. [3 ]
Dayag, Ariane Marie S. [3 ]
机构
[1] Univ Philippines, Coll Med, Dept Clin Epidemiol, Manila 1000, Philippines
[2] Univ Philippines, Coll Publ Hlth, Dept Parasitol, Manila 1000, Philippines
[3] Univ Philippines, Natl Inst Hlth, Filariasis Study Grp, Manila 1000, Philippines
基金
美国国家卫生研究院;
关键词
D O I
10.1186/1756-3305-1-14
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Background: Mass drug administration (MDA) has been one of the strategies endorsed by the World Health Assembly for lymphatic filariasis (LF) elimination. Many factors, however, affect the acceptability of the MDA in the Philippines with acceptability defined as the ingestion of drugs - diethylcarbamazine and albendazole during MDA. These drugs were mainly distributed in fixed sites and mopping up activities were conducted through house-to-house visits to increase treatment coverage. The aim of conducting the study was to determine the MDA acceptance rate among a population endemic for LF, and the factors associated with MDA acceptance. Methods: In April 2005, a stratified cluster survey involving 437 respondents aged 18 years old and above in Agusan del Sur, Philippines was conducted. Key informant interviews and focused group discussions were performed among community leaders and health service providers. Descriptive statistics and coverage estimates were calculated with appropriate sampling weights applied to all analyses. Factors assessed for association with receipt of antifilarial drugs and MDA acceptance were respondents' socio-demographic characteristics, knowledge, attitudes, beliefs and perceptions on LF. Pearson chi-squared test was used to determine factors associated with MDA acceptance. Results: Results showed that 63.3% of the sampled population received the antifilarial drugs; of these, 94.5% ingested the drugs, yielding an acceptance rate of 60%. Half of the sampled population received the drugs from a fixed site, while only 13% was mopped up. A majority of the sampled population were aware of LF and MDA. Knowledge on LF prevention, cause, treatment and diagnosis and adverse events was low to moderate. Knowledge on LF and perceived benefits of antifilarial drugs were found to be associated with MDA acceptance (p = 0.08). Health workers remain the front liners in the MDA implementation. Local government units were aware of LF and MDA, but support was insufficient. Conclusion: The proportion of the sampled population that received and ingested the antifilarial drugs was much lower than the reported coverage. The target coverage rate of 85% may be achieved with sufficient groundwork for MDA, buy-in from the local government, greater efforts exerted to increase the people's knowledge on LF and MDA and their understanding of perceived benefits of the drugs. These would contribute to the successful elimination of LF in the province.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance
    Mohammad A Hussain
    Ashok K Sitha
    Subhashisa Swain
    Shridhar Kadam
    Sanghamitra Pati
    [J]. Infectious Diseases of Poverty, 3
  • [32] Mass Drug Administration (MDA) for Elimination of Lymphatic Filariasis: Experiences from Nayagarh District of Odisha, India
    Bhatia, Vikas
    Giri, Prajna Paramita
    Sahoo, Soumya Swaroop
    Preeti, P. S.
    Sahu, Dinesh Prasad
    [J]. INDIAN JOURNAL OF COMMUNITY HEALTH, 2018, 30 (03) : 287 - 292
  • [33] Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review
    Halim, Ahmad Farid Nazmi Abdul
    Ahmad, Dzulfitree
    Yn, Jane Ling Miaw
    Masdor, Noor Azreen
    Ramly, Nurfatehar
    Othman, Rahayu
    Kandayah, Thinakaran
    Hassan, Mohd Rohaizat
    Dapari, Rahmat
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (19)
  • [34] Community and Drug Distributor Perceptions and Experiences of Mass Drug Administration for the Elimination of Lymphatic Filariasis: A Rapid Review of Qualitative Research
    Ames, Heather Melanie R.
    Zuske, Meike
    King, Jonathan D.
    Steinmann, Peter
    Bosch-Capblanch, Xavier
    [J]. HIGHLIGHTING OPERATIONAL AND IMPLEMENTATION RESEARCH FOR CONTROL OF HELMINTHIASIS, 2019, 103 : 117 - +
  • [35] A MULTICENTER STUDY OF THE SAFETY OF TRIPLE DRUG MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS
    Weil, Gary J.
    Bogus, Joshua
    Dubray, Christine
    Fischer, Peter U.
    Jambulingam, P.
    King, Christopher L.
    Lemoine, Jean Frantz
    O'Brian, Katiuscia
    Robinson, Leanne J.
    Supali, Taniawati
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 239 - 239
  • [36] Comparing PCR and mosquito dissection for monitoring the progress of mass drug administration programs for the elimination of lymphatic filariasis in Tanzania
    Laney, Sandra J.
    Magesa, Stephen
    Pedersen, Erling M.
    Simonsen, Paul E.
    Ishengoma, Deus
    Rwegoshora, Theophil
    Occhialini, Lea T.
    Buttaro, Caitlin J.
    Williams, Steven A.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 141 - 141
  • [37] Mass Drug Administration for the Elimination of Lymphatic Filariasis - Port-au-Prince, Haiti, 2011-2012
    Streit, Thomas
    Desir, Luccene
    Oscar, Roland
    Lemoine, Jean Frantz
    Purcell, Nora Colleen
    Keller, Angela
    Lammie, Patrick J.
    Deming, Michael
    De Rochars, Valery E. Madsen Beau
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2013, 62 (23): : 466 - 468
  • [38] Coverage and Awareness of and Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis in Burdwan District, West Bengal, India
    Roy, Rabindra Nath
    Sarkar, Aditya Prasad
    Misra, Raghunath
    Chakroborty, Amitava
    Mondal, Tusar Kanti
    Bag, Kanad
    [J]. JOURNAL OF HEALTH POPULATION AND NUTRITION, 2013, 31 (02) : 171 - 177
  • [39] Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study
    Banerjee, Sitikantha
    Bandyopadhyay, Kajari
    Khan, Mubashshera F.
    Akkilagunta, Sujiv
    Selvaraj, Kalaiselvi
    Tripathy, Jaya P.
    Solanki, Ranjan
    Kushwaha, Arvind S.
    Deshmukh, Pradeep
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (09) : 3009 - 3014
  • [40] Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
    Taleo F.
    Taleo G.
    Graves P.M.
    Wood P.
    Kim S.H.
    Ozaki M.
    Joseph H.
    Chu B.
    Pavluck A.
    Yajima A.
    Melrose W.
    Ichimori K.
    Capuano C.
    [J]. Tropical Medicine and Health, 45 (1)